FOX News: Business
FOXBusiness.com - Breaking news and video. Latest Current News: News, Investing, Technology, Personal Finance, Business Leaders, Travel, On Air, Small Business.
Updated: 43 min 4 sec ago
While there was good news in the report, the negative points may weigh most heavily.
Chipmaker Maxim's partnership with NVIDIA could boost its automotive growth.
GoPro will attempt major damage control.
A new store strategy could undo the gains the retailer's made.
The ongoing gene therapy revolution could send these three biotech stocks soaring. Here's what you need to know right now.
Two helpful tools can give you an idea of how big that check will be.
The beaten-down burrito chain comes into the new year with an opportunity to bounce back. Can it execute?
This Fool puts the puzzle pieces together.
Here's how this drugmaker could become a top-performing dividend stock in 2018 and beyond.
After the failed T-Mobile-Sprint merger, network spending is ramping up.
On Feb. 6, when the entertainment giant reports first-quarter fiscal 2018 results, investors' primary focus should be on how well the company is setting itself up for long-term growth.
The sector keeps growing and growing and growing.
United Airlines plans to expand its capacity significantly over the next three years. However, this won't necessarily spark a new round of fare wars with Spirit Airlines.
The news might be better than you'd think.
"Maze Runner: The Death Cure" is the highest grossing film of the weekend, but according to studio estimates Sunday, many moviegoers also chose the first weekend after Oscar nominations to catch up with some awards contenders like "The Shape of Water" which had its highest grossing frame with $5.7 million.
Early viewership numbers show the Overwatch League is off to a strong start, but management has one main obstacle to overcome to make it the definitive esport.
These best-of-breed media companies are where long-term investors should look to allocate capital.
Chalk up another year of double-digit legal weed sales growth for the Rocky Mountain state -- but don't get too excited.
These small biotechs could be prime buyout candidates in 2018.